We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
An SI Board Since August 2000
Posts SubjectMarks Bans Symbol
146 8 0 DDDP
Emcee:  Harold Neely Type:  Moderated
NEW YORK, Aug 4 (Reuters) - Stock of 3-Dimensional
Pharmaceuticals Inc. climbed roughly 22 percent on
Friday after the biotechnology company began trading on the
Stock of 3-Dimensional jumped to 18-5/16, up 3-5/16 from
its offering price. The stock ranked among the leading
percentage gainers on the technology-rich Nasdaq. Meanwhile,
the Nasdaq composite index edged 0.01 percent higher to
3-Dimensional, which offers technologies to accelerate the
discovery process of drugs, had priced 5 million shares at $15
each, the top of its expected range.
The company boosted its offering by 1 million common shares
to 5 million, while keeping the price range steady at $13-$15 a
share. The Exton, Pa.-based company raised $75 million through
the deal with underwriters Bear Stearns, Chase H&Q and U.S.
Bancorp Piper Jaffray.
It plans to use the proceeds from the IPO for research and
development, possible acquisitions of technologies or targets,
expansion of its facilities and other general corporate and
working capital purposes.
The company has a market capitalisation of $351.6 million
based on 19.2 million shares outstanding and its current stock
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
146urrrrrrrrrrrrrrrrrrrrrrggggggggggggggggghhhhhhhhhhhhh....... No. Never trust ascaram(o)uche-8/31/2003
145Thanks, Stefaan, found it on the munch thread.tom pope-8/31/2003
144Thanks, Stefaan. Beneficially for stockholders?tom pope-8/31/2003
143Tom Dddp was munced cheers Sdalroi-8/31/2003
142Whatever happened to DDDP? Just meandering this morning, and Yahoo draws a blanktom pope-8/31/2003
141J.D.: Love the company. I'm just concerned that this "rock and a hardscaram(o)uche-1/19/2003
140I owned Sibia at the time of acquisition. I did not participate in DDDP. Howeverjayhawk969-1/19/2003
139Companies with "no way out" and which are receiving insufficient interscaram(o)uche-1/18/2003
138Any thoughts on what this portends for other drug discovery microcaps? Lexg etc.jayhawk969-1/18/2003
137No, but good luck. I took the cash and walked. Walked ticked. I feel as thougscaram(o)uche-1/17/2003
136only one year........ Message 16861048scaram(o)uche-1/17/2003
135Looks like there are lots of folks waiting to see if another offer comes in. OnFindit-1/17/2003
134>> Whish I can kick their fat ASS << 1. My first reaction, in the scaram(o)uche-1/16/2003
133<<The upside? Scratch one more management team that didn't have a concMiljenko Zuanic-1/16/2003
132>>After 2002, I'm not confident enough to answer that question directlmopgcw-1/16/2003
131After 2002, I'm not confident enough to answer that question directly. You keokalani'nui-1/16/2003
130any good redeploy ideas/pointers?mopgcw-1/16/2003
129Nope. It feels to me, <i>feels</i>, like the supply of several BT mkeokalani'nui-1/16/2003
128not holding out for that last dime?mopgcw-1/16/2003
127Highly doubtful, but never say never. Too late for me anyway, all gone.keokalani'nui-1/16/2003
126Pretty sucky, overall. Perhaps JNJ doesn't mention the potential of their mscaram(o)uche-1/16/2003
125indeed. think i will break even on this one. alas. any chance of another suitmopgcw-1/16/2003
124Reality and perception were quite separated, for me. JnJ doesn't once mentikeokalani'nui-1/16/2003
123Johnson&Johnson to Acquire 3-Dimensional Pharmaceuticals, Inc. Acquisition tmopgcw-1/16/2003
122Message 18409358scaram(o)uche-1/6/2003
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):